Abliva
1 known investors
Abliva is a biotech company developing treatments for primary mitochondrial disease, a genetic condition affecting cells' ability to convert energy. Its focus is on identifying and treating patients with mutations underlying mitochondrial disease.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Abliva do?
- Abliva is a biotech company developing treatments for primary mitochondrial disease, a genetic condition affecting cells' ability to convert energy. Its focus is on identifying and treating patients with mutations underlying mitochondrial disease.
- Who are Abliva's investors?
- Abliva's investors include Hadean Ventures.